Neurocrine Biosciences (NBIX) P/FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | 34.6 | 0.00 | 0.00 | 24.6 | 18.8 | 20.2 | |||
| Changes by years, y/y, % | -16% | -100% | -23% | -14.4% | |||||
Neurocrine Biosciences. P/FCF
Neurocrine Biosciences. P/FCF, changes, %
Neurocrine Biosciences (NBIX) P/FCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/FCF | 22.4 | 23.5 | 23.5 | 18.8 | 15.9 | 20.2 | ||
| Changes by years, y/y, % | -11% | -23% | -29% | |||||
| Changes by quarters, q/q, % | -9% | +5% | 0% | -20% | -16% | |||